Benjamin Lewis Franc, MD
Nuclear Medicine · Stanford
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 1
- 1 carrier
- Offices
- 6
Offices
6 locations · Stanford Health Care · 3,152 clinicians in this group
Looking this up.
Hospitals listed: Stanford Health Care · Stanford Health Care Tri-Valley. That is not proof they admit you there this week.
Plans that list them
1 plan · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Franc’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
California Medical Board record
Licence A75921 · Current
Licensed to practise in California · since 2001 · expires 2028-12-31 · University of Southern California Keck School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Surgery centers they own
- Radiological Associates of Sacramento Medical Group, Inc.Medical Group Practice · Sacramento, CA2% owner since 2009 · accredited by AAAHCAccreditation Renewed1 inspection · last 2013-05-15
- Radiological Associates of Sacramento Medical Group, Inc. - 29th Street MRIMedical Group Practice · Sacramento, CA2% owner since 2009 · accredited by AAAHCAccreditation RenewedNo inspections published
- Radiological Associates of Sacramento Medical Group, Inc. - Auburn Imaging CenterMedical Group Practice · Auburn, CA2% owner since 2009 · accredited by AAAHCAccreditation RenewedNo inspections published
- Radiological Associates of Sacramento Medical Group, Inc. - Auburn Radiation Oncology CenterMedical Group Practice · Auburn, CA2% owner since 2009 · accredited by AAAHCAccreditation RenewedNo inspections published
- Radiological Associates of Sacramento Medical Group, Inc. - Campus Commons ImagingMedical Group Practice · Sacramento, CA2% owner since 2009 · accredited by AAAHCAccreditation RenewedNo inspections published
- Radiological Associates of Sacramento Medical Group, Inc. - Capitol Imaging CenterMedical Group Practice · Sacramento, CA2% owner since 2009 · accredited by AAAHCAccreditation RenewedNo inspections published
- Radiological Associates of Sacramento Medical Group, Inc. - Carmichael ImagingMedical Group Practice · Carmichael, CA2% owner since 2009 · accredited by AAAHCAccreditation RenewedNo inspections published
- Radiological Associates of Sacramento Medical Group, Inc. - Carmichael Open MRIMedical Group Practice · Carmichael, CA2% owner since 2009 · accredited by AAAHCAccreditation RenewedNo inspections published
- Radiological Associates of Sacramento Medical Group, Inc. - Folsom ImagingMedical Group Practice · Folsom, CA2% owner since 2009 · accredited by AAAHCAccreditation RenewedNo inspections published
- Radiological Associates of Sacramento Medical Group, Inc. - Ft. Sutter DiagnosticMedical Group Practice · Sacramento, CA2% owner since 2009 · accredited by AAAHCAccreditation RenewedNo inspections published
- Radiological Associates of Sacramento Medical Group, Inc. - Gynecologic OncologyMedical Group Practice · Roseville, CA2% owner since 2009 · accredited by AAAHCAccreditation RenewedNo inspections published
- Radiological Associates of Sacramento Medical Group, Inc. - Interventional ClinicMedical Group Practice · Sacramento, CA2% owner since 2009 · accredited by AAAHCAccreditation RenewedNo inspections published
- Radiological Associates of Sacramento Medical Group, Inc. - MRI Center at Sutter MemorialMedical Group Practice · Sacramento, CA2% owner since 2009 · accredited by AAAHCAccreditation RenewedNo inspections published
- Radiological Associates of Sacramento Medical Group, Inc. - MRI at Roseville Medical CenterMedical Group Practice · Roseville, CA2% owner since 2009 · accredited by AAAHCAccreditation RenewedNo inspections published
- Radiological Associates of Sacramento Medical Group, Inc. - Marshall Radiation Oncology CenterMedical Group Practice · Cameron Park, CA2% owner since 2009 · accredited by AAAHCAccreditation RenewedNo inspections published
- Radiological Associates of Sacramento Medical Group, Inc. - Mercy General Radiation Oncology CenterMedical Group Practice · Sacramento, CA2% owner since 2009 · accredited by AAAHCAccreditation RenewedNo inspections published
- Radiological Associates of Sacramento Medical Group, Inc. - Mercy San Juan Radiation Oncology CenterMedical Group Practice · Carmichael, CA2% owner since 2009 · accredited by AAAHCAccreditation RenewedNo inspections published
- Radiological Associates of Sacramento Medical Group, Inc. - Neurointerventional ClinicMedical Group Practice · Sacramento, CA2% owner since 2009 · accredited by AAAHCAccreditation RenewedNo inspections published
- Radiological Associates of Sacramento Medical Group, Inc. - Northern California Vascular InstituteMedical Group Practice · Roseville, CA2% owner since 2009 · accredited by AAAHCAccreditation RenewedNo inspections published
- Radiological Associates of Sacramento Medical Group, Inc. - Northern California Vascular Institute IIMedical Group Practice · Roseville, CA2% owner since 2009 · accredited by AAAHCAccreditation RenewedNo inspections published
- Radiological Associates of Sacramento Medical Group, Inc. - Roseville Imaging CenterMedical Group Practice · Roseville, CA2% owner since 2009 · accredited by AAAHCAccreditation RenewedNo inspections published
- Radiological Associates of Sacramento Medical Group, Inc. - Roseville PET & Nuclear Medicine ImagingMedical Group Practice · Roseville, CA2% owner since 2009 · accredited by AAAHCAccreditation RenewedNo inspections published
- Radiological Associates of Sacramento Medical Group, Inc. - Roseville Radiation Oncology CenterMedical Group Practice · Roseville, CA2% owner since 2009 · accredited by AAAHCAccreditation RenewedNo inspections published
- Radiological Associates of Sacramento Medical Group, Inc. - Sacramento Clinic for Hematology and Medical OncologyMedical Group Practice · Carmichael, CA2% owner since 2009 · accredited by AAAHCAccreditation RenewedNo inspections published
- Radiological Associates of Sacramento Medical Group, Inc. - Sacramento Clinic for Hemotology and Medical OncologyMedical Group Practice · Sacramento, CA2% owner since 2009 · accredited by AAAHCAccreditation RenewedNo inspections published
- Radiological Associates of Sacramento Medical Group, Inc. - Solano Radiation Oncology CenterMedical Group Practice · Vacaville, CA2% owner since 2009 · accredited by AAAHCAccreditation RenewedNo inspections published
- Radiological Associates of Sacramento Medical Group, Inc. - South Imaging CenterMedical Group Practice · Sacramento, CA2% owner since 2009 · accredited by AAAHCAccreditation RenewedNo inspections published
- Radiological Associates of Sacramento Medical Group, Inc. - Sutter Cancer Center Radiation Oncology CenterMedical Group Practice · Sacramento, CA2% owner since 2009 · accredited by AAAHCAccreditation RenewedNo inspections published
- Radiological Associates of Sacramento Medical Group, Inc. - Urology Associates of Northern CaliforniaMedical Group Practice · Carmichael, CA2% owner since 2009 · accredited by AAAHCAccreditation RenewedNo inspections published
- Radiological Associates of Sacramento Medical Group, Inc. - Urology Associates of Northern CaliforniaMedical Group Practice · Folsom, CA2% owner since 2009 · accredited by AAAHCAccreditation RenewedNo inspections published
- Radiological Associates of Sacramento Medical Group, Inc. - Urology Associates of Northern CaliforniaMedical Group Practice · Sacramento, CA2% owner since 2009 · accredited by AAAHCAccreditation RenewedNo inspections published
- Radiological Associates of Sacramento Medical Group, Inc.-Folsom Imaging IIFolsom, CA2% owner since 2009 · accredited by AAAHCAccreditation RenewedNo inspections published
Hospitals they work in
2 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend itOverall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
- Stanford Health Care Tri-ValleyPleasanton, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Stanford Health Care, which runs 3 hospitalsPatients rate it 3 of 5 · 74% would definitely recommend itOverall rating: 5 of 5 starsBetter than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.178, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.237, Oct 2024 – Sep 2025
See every measure and the patient survey for Stanford Health Care
Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 5.31 (4.24 to 6.37) · 8,661 cases | Worse | Jul 2022 – Jun 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 14.1 (12.7 to 15.7) · 2,191 cases | Worse | Jan 2024 – Dec 2024 |
| Postoperative respiratory failure rateComplications and deaths | 4.08 (1.95 to 6.21) · 5,296 cases | Better | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.317 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.446 | Better | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.241 | Better | Oct 2024 – Sep 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.7 (0.6 to 0.9) · 3,348 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.06 (0.45 to 1.67) · 5,374 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.86 (0.72 to 1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 166.09 (137.88 to 194.3) · 470 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.1 · 192 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.4 · 146 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.7 · 253 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 6.3 · 880 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 935 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.7 · 501 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.1 · 7,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.13 (0 to 0.27) · 20,799 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.14 to 0.43) · 23,182 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 0.94 (0.2 to 1.68) · 5,694 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.36 (1.54 to 3.19) · 7,846 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.2 (3.76 to 6.64) · 5,603 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.38 (0.23 to 2.53) · 2,211 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.52 (0.21 to 0.83) · 19,915 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.6 · 416 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.869 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.857 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.368 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 16.2 · 247 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.5 · 1,021 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 47.8 · 258 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -1.6 · 990 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 20.8 · 976 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.5 · 959 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (4.4 to 6.2) · 2,191 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.1 · 425 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.6 · 158 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 183 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.7 (10.4 to 15.4) · 4,578 cases | No different | Jan 2022 – Dec 2024 |
What patients said (6,810 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 82% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 63% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 89% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 79% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 83% |
| Staff "always" explained possible side effects | 50% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
See every measure and the patient survey for Stanford Health Care Tri-Valley
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 0 worse of 7 measures. Readmissions: 2 better, 7 the same, 0 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.178 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.237 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.79 (0 to 1.73) · 1,041 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.79 (0.5 to 1.08) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 145.81 (96.5 to 195.12) · 72 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.9 · 55 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 8.6 · 92 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 12.5 · 96 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.5 · 395 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 391 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.1 · 162 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3 · 1,736 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.16 (0 to 0.37) · 4,425 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.22 (0.02 to 0.41) · 4,771 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.45 (1.46 to 5.44) · 1,403 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.5 (0.05 to 2.94) · 645 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 1.81 (0.38 to 3.24) · 1,279 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 8.53 (3.2 to 13.85) · 639 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.15 (1.89 to 8.41) · 648 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.61 (0.14 to 3.07) · 370 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.16 (0 to 0.83) · 4,160 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4 · 74 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.369 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 1.112 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 13.1 · 110 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.1 · 437 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -5.8 · 94 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -19.3 · 456 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -0.3 · 402 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 15.8 · 358 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 6.8 (4.7 to 9.6) · 198 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 10.1 (7.5 to 13.6) · 198 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.3 · 80 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.9 · 46 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.3 · 92 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.4 (9.6 to 16.2) · 1,532 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.8 to 1.2) · 929 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,268 patients answered, 26% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 65% |
| Nurses "always" communicated well | 77% |
| Doctors "always" communicated well | 79% |
| Staff "always" explained | 58% |
| Yes, staff "did" give patients this information | 88% |
| Yes, staff "did" give patients information about help after discharge | 88% |
| Doctors "always" explained things so they could understand | 74% |
| Doctors "always" listened carefully | 78% |
| Doctors "always" treated them with courtesy and respect | 86% |
| Patients who gave a rating of "9" or "10" (high) | 70% |
| Staff "always" explained new medications | 72% |
| Nurses "always" explained things so they could understand | 73% |
| Nurses "always" listened carefully | 74% |
| Nurses "always" treated them with courtesy and respect | 84% |
| "Always" quiet at night | 42% |
| "YES", patients would definitely recommend the hospital | 74% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 89% |
Original Medicare doctor bills
$78,608
Medicare paid this office $78,608 for 1,571 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Nuclear medicine study from skull base to mid-thigh with ct scan | 204 | $19,935 | $94 |
| Nuclear medicine study whole body with ct scan | 108 | $10,884 | $96 |
| Nuclear medicine study from skull base to mid-thigh with ct scan | 99 | $9,350 | $92 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 105 | $6,843 | $65 |
| Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 17 | $4,802 | $282 |
See all 20 services
| Nuclear medicine study from skull base to mid-thigh with ct scan | 204 | $19,935 | $94 |
| Nuclear medicine study whole body with ct scan | 108 | $10,884 | $96 |
| Nuclear medicine study from skull base to mid-thigh with ct scan | 99 | $9,350 | $92 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 105 | $6,843 | $65 |
| Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 17 | $4,802 | $282 |
| Dxa bone density measurement of hip, pelvis, spine | 447 | $4,710 | $11 |
| Nuclear medicine study whole body with ct scan | 42 | $3,612 | $84 |
| Dxa bone density measurement of hip, pelvis, spine | 303 | $3,223 | $11 |
| Nuclear medicine study, spect imaging with concurrent ct scan, 1 area or single acquisition, single day imaging | 46 | $2,558 | $56 |
| Nuclear medicine studies of blood flow in heart muscle at rest and with stress with concurrent ct scan | 15 | $1,178 | $79 |
| Nuclear medicine study of lymphatic system | 22 | $1,083 | $49 |
| Nuclear medicine study, spect imaging with concurrent ct scan, at least 2 areas or separate acquisitions, single day imaging, or single area or acquisition over multiple days | 11 | $911 | $83 |
| Nuclear medicine study of bone and/or joint whole body | 26 | $905 | $34 |
| Nuclear medicine study, spect imaging, 1 area or single acquisition, single day imaging | 21 | $810 | $39 |
| Nuclear medicine study of stomach to assess emptying | 26 | $761 | $29 |
| Nuclear medicine study limited area | 11 | $695 | $63 |
| Nuclear medicine study of lung ventilation and circulation | 16 | $663 | $41 |
| Nuclear medicine study, whole body | 11 | $325 | $30 |
| Nuclear medicine study, 1 area | 11 | $274 | $25 |
| Piflufolastat f-18, diagnostic, 1 millicurie | 22 | $0 | $0 |
Who their Medicare patients are
1,571 Original Medicare patients in 2024. Average age 74 · Under 65 6% · 85 and older 11% · Women 68% · Also on Medicaid 19% · Health risk score 1.67. At or below the middle of the specialty; the typical nuclear medicine clinician is at 1.94.
Conditions among them: High blood pressure 66% · Cancer 35% · Diabetes 26% · Coronary heart disease 26% · Chronic kidney disease 25% · Atrial fibrillation 18% · Depression 18% · Heart failure 16% · COPD 12% · Stroke 8% · Dementia 7%.
The office billed $2,803,224, Medicare allowed $102,637 and paid $78,608; for 1,694 services of 41 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 1,571 | 1,694 | 74 | 1.67 | $2,803,224 | $78,608 |
| 2023 | 1,579 | 1,733 | 74 | 1.84 | $2,388,213 | $97,519 |
| 2022 | 1,173 | 1,306 | 74 | 1.67 | $934,994 | $65,930 |
| 2021 | 1,638 | 1,847 | 74 | 1.63 | $1,117,389 | $91,422 |
| 2020 | 1,107 | 1,211 | 74 | 1.93 | $709,348 | $62,888 |
| 2019 | 1,500 | 1,623 | 73 | 1.90 | $561,370 | $87,484 |
| 2018 | 639 | 728 | 71 | 2.13 | $904,870 | $47,405 |
| 2017 | 496 | 568 | 70 | 2.49 | $787,773 | $38,292 |
| 2016 | 410 | 465 | 70 | 2.24 | $639,765 | $31,031 |
| 2015 | 418 | 475 | 70 | 2.34 | $599,124 | $33,584 |
| 2014 | 749 | 2,380 | 72 | 1.58 | $2,798,712 | $733,796 |
| 2013 | 817 | 3,079 | 73 | 1.62 | $4,371,345 | $773,033 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 16 services
| Nuclear medicine study from skull base to mid-thigh with ct scan | 332 | $35,318 | $100 |
| Nuclear medicine study from skull base to mid-thigh with ct scan | 126 | $13,440 | $101 |
| Nuclear medicine study whole body with ct scan | 110 | $11,431 | $97 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 113 | $7,503 | $66 |
| Nuclear medicine study whole body with ct scan | 61 | $6,497 | $98 |
| Dxa bone density measurement of hip, pelvis, spine | 479 | $5,217 | $11 |
| Nuclear medicine study, spect imaging with concurrent ct scan, 1 area or single acquisition, single day imaging | 61 | $3,613 | $56 |
| Nuclear medicine studies of blood flow in heart muscle at rest and with stress with concurrent ct scan | 16 | $1,305 | $82 |
| Nuclear medicine study of lymphatic system | 24 | $1,182 | $49 |
| Nuclear medicine study of bone and/or joint whole body | 31 | $1,128 | $34 |
| Nuclear medicine study of stomach to assess emptying | 34 | $1,107 | $33 |
| Dxa bone density measurement of hip, pelvis, spine | 102 | $1,100 | $11 |
| Nuclear medicine study of lung ventilation and circulation | 19 | $828 | $44 |
| Nuclear medicine study of parathyroid with spect and ct scan | 14 | $682 | $49 |
| Nuclear medicine study of lymphatic system | 13 | $669 | $51 |
| Nuclear medicine study, whole body | 15 | $442 | $29 |
2022: 15 services
| Nuclear medicine study from skull base to mid-thigh with ct scan | 174 | $19,019 | $103 |
| Nuclear medicine study from skull base to mid-thigh with ct scan | 74 | $8,210 | $104 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 109 | $6,901 | $63 |
| Nuclear medicine study whole body with ct scan | 59 | $6,387 | $105 |
| Dxa bone density measurement of hip, pelvis, spine | 419 | $4,611 | $11 |
| Nuclear medicine study, spect imaging with concurrent ct scan, 1 area or single acquisition, single day imaging | 77 | $4,320 | $56 |
| Nuclear medicine study whole body with ct scan | 34 | $3,835 | $104 |
| Nuclear medicine study of bone and/or joint whole body | 38 | $1,232 | $32 |
| Nuclear medicine study from skull base to mid-thigh | 14 | $1,170 | $84 |
| Dxa bone density measurement of hip, pelvis, spine | 94 | $1,021 | $11 |
| Nuclear medicine study of lymphatic system | 22 | $1,015 | $46 |
| Nuclear medicine study of parathyroid with spect and ct scan | 14 | $883 | $63 |
| Radioactive drug therapy through a vein | 11 | $790 | $72 |
| Nuclear medicine study, whole body | 17 | $554 | $33 |
| Nuclear medicine study of stomach to assess emptying | 15 | $477 | $32 |
2021: 16 services
| Nuclear medicine study from skull base to mid-thigh with ct scan | 278 | $29,941 | $101 |
| Nuclear medicine study whole body with ct scan | 99 | $11,197 | $105 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 163 | $11,196 | $69 |
| Nuclear medicine study, spect imaging with concurrent ct scan, 1 area or single acquisition, single day imaging | 128 | $8,252 | $63 |
| Dxa bone density measurement of hip, pelvis, spine | 580 | $6,498 | $11 |
| Nuclear medicine study from skull base to mid-thigh with ct scan | 53 | $5,736 | $108 |
| Nuclear medicine study of bone and/or joint whole body | 88 | $3,375 | $37 |
| Nuclear medicine study whole body with ct scan | 23 | $2,502 | $109 |
| Dxa bone density measurement of hip, pelvis, spine | 158 | $1,744 | $11 |
| Nuclear medicine study of lymphatic system | 24 | $1,166 | $49 |
| Nuclear medicine study of stomach to assess emptying | 30 | $1,059 | $35 |
| Nuclear medicine study of parathyroid with spect and ct scan | 12 | $830 | $69 |
| Nuclear medicine study of lung circulation | 23 | $725 | $32 |
| Nuclear medicine study of lymphatic system | 11 | $528 | $48 |
| Nuclear medicine study, whole body | 14 | $422 | $30 |
| Nuclear medicine study of stomach to assess emptying | 11 | $381 | $35 |
2020: 16 services
| Nuclear medicine study from skull base to mid-thigh with ct scan | 172 | $17,933 | $101 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 126 | $7,918 | $63 |
| Nuclear medicine study from skull base to mid-thigh with ct scan | 72 | $7,552 | $98 |
| Nuclear medicine study whole body with ct scan | 58 | $6,607 | $108 |
| Dxa bone density measurement of hip, pelvis, spine | 361 | $4,094 | $11 |
| Nuclear medicine study, spect imaging with concurrent ct scan, 1 area or single acquisition, single day imaging | 45 | $3,165 | $67 |
| Nuclear medicine study whole body with ct scan | 25 | $2,602 | $93 |
| Nuclear medicine study of bone and/or joint whole body | 57 | $2,042 | $35 |
| Nuclear medicine study of lymphatic system | 20 | $1,019 | $51 |
| Nuclear medicine study of stomach to assess emptying | 31 | $967 | $31 |
| Nuclear medicine study of parathyroid with spect and ct scan | 12 | $799 | $67 |
| Nuclear medicine study, spect imaging, 1 area or single acquisition, single day imaging | 15 | $724 | $48 |
| Dxa bone density measurement of hip, pelvis, spine | 55 | $617 | $11 |
| Nuclear medicine study of kidney, blood, flow, and function with drug administration | 11 | $488 | $44 |
| Nuclear medicine study of liver and bile duct system | 13 | $435 | $33 |
| Nuclear medicine study of lung circulation | 12 | $406 | $34 |
2019: 18 services
| Nuclear medicine study from skull base to mid-thigh with ct scan | 243 | $27,039 | $106 |
| Nuclear medicine study from skull base to mid-thigh with ct scan | 112 | $12,921 | $109 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 181 | $12,196 | $67 |
| Nuclear medicine study whole body with ct scan | 73 | $7,861 | $105 |
| Dxa bone density measurement of hip, pelvis, spine | 478 | $5,377 | $11 |
| Nuclear medicine study whole body with ct scan | 28 | $3,299 | $110 |
| Nuclear medicine study of bone and/or joint whole body | 81 | $2,936 | $34 |
| Nuclear medicine study of lung ventilation and circulation | 36 | $1,686 | $47 |
| Nuclear medicine study of lymphatic system | 23 | $1,178 | $51 |
| Nuclear medicine study of stomach to assess emptying | 33 | $1,145 | $35 |
| Radioactive drug therapy through a vein | 12 | $1,098 | $78 |
| Nuclear medicine study of parathyroid with spect and ct scan | 13 | $891 | $69 |
| Nuclear medicine study, spect imaging, 1 area or single acquisition, single day imaging | 19 | $857 | $45 |
| Nuclear medicine study of heart muscle with metabolic evaluation | 13 | $824 | $63 |
| Nuclear medicine study of heart muscle at rest and with stress and spect | 13 | $742 | $57 |
| Dxa bone density measurement of hip, pelvis, spine | 64 | $716 | $11 |
| Nuclear medicine study of liver and bile duct system with use of drugs | 12 | $489 | $41 |
| Nuclear medicine study of liver and bile duct system | 12 | $401 | $33 |
2018: 16 services
| Nuclear medicine study from skull base to mid-thigh with ct scan | 136 | $14,079 | $101 |
| Nuclear medicine study whole body with ct scan | 68 | $7,498 | $103 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 68 | $4,391 | $65 |
| Nuclear medicine study from skull base to mid-thigh | 45 | $3,508 | $78 |
| Nuclear medicine study of bone and/or joint whole body | 81 | $3,109 | $34 |
| Nuclear medicine study, spect imaging, 1 area or single acquisition, single day imaging | 36 | $1,656 | $44 |
| Nuclear medicine studies of blood flow in heart muscle at rest and with stress | 21 | $1,535 | $73 |
| Radioactive drug therapy through a vein | 18 | $1,472 | $74 |
| Nuclear medicine study of lung ventilation and circulation | 31 | $1,341 | $43 |
| Nuclear medicine study of parathyroid with spect | 24 | $1,154 | $48 |
| Nuclear medicine study of lymphatic system | 21 | $1,097 | $52 |
| Nuclear medicine study whole body | 11 | $901 | $82 |
| Nuclear medicine study of heart muscle with metabolic evaluation | 12 | $650 | $54 |
| Nuclear medicine study of brain | 11 | $580 | $53 |
| Injection of radioactive material for x-ray identification of lymph node | 14 | $524 | $37 |
| Dxa bone density measurement of hip, pelvis, spine | 25 | $290 | $12 |
2017: 12 services
| Nuclear medicine study from skull base to mid-thigh with ct scan | 95 | $9,870 | $99 |
| Nuclear medicine study whole body with ct scan | 60 | $6,557 | $99 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 60 | $3,922 | $65 |
| Radioactive drug therapy through a vein | 26 | $3,120 | $84 |
| Nuclear medicine study of bone and/or joint whole body | 58 | $2,109 | $33 |
| Nuclear medicine study from skull base to mid-thigh | 22 | $1,769 | $80 |
| Nuclear medicine studies of blood flow in heart muscle at rest and with stress | 21 | $1,536 | $73 |
| Nuclear medicine study whole body | 16 | $1,405 | $88 |
| Nuclear medicine study of lung ventilation and circulation | 30 | $1,335 | $45 |
| Nuclear medicine study of parathyroid with spect | 24 | $1,201 | $50 |
| Nuclear medicine study, spect imaging, 1 area or single acquisition, single day imaging | 19 | $933 | $47 |
| Nuclear medicine study of stomach to assess emptying | 12 | $386 | $32 |
2016: 9 services
| Nuclear medicine study whole body with ct scan | 73 | $7,523 | $96 |
| Nuclear medicine study from skull base to mid-thigh with ct scan | 68 | $7,402 | $104 |
| Nuclear medicine study of bone and/or joint whole body | 85 | $3,531 | $38 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 42 | $2,713 | $65 |
| Nuclear medicine study from skull base to mid-thigh | 19 | $1,614 | $85 |
| Radioactive drug therapy through a vein | 13 | $1,211 | $81 |
| Nuclear medicine study of lung ventilation and circulation | 22 | $1,142 | $46 |
| Nuclear medicine study of parathyroid with spect | 18 | $866 | $48 |
| Nuclear medicine study, spect imaging, 1 area or single acquisition, single day imaging | 13 | $601 | $46 |
2015: 10 services
| Nuclear medicine study whole body with ct scan | 94 | $10,182 | $105 |
| Nuclear medicine study from skull base to mid-thigh with ct scan | 75 | $9,103 | $107 |
| Nuclear medicine study of bone and/or joint whole body | 64 | $2,630 | $37 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 28 | $1,778 | $63 |
| Nuclear medicine studies of blood flow in heart muscle at rest and with stress | 19 | $1,559 | $82 |
| Radioactive drug therapy through a vein | 11 | $1,457 | $86 |
| Nuclear medicine study of lung ventilation and circulation | 28 | $1,294 | $46 |
| Nuclear medicine studies of heart muscle at rest and with stress with single 2d image | 23 | $1,034 | $45 |
| Nuclear medicine study of parathyroid with spect | 14 | $745 | $53 |
| Nuclear medicine study, spect imaging, 1 area or single acquisition, single day imaging | 11 | $469 | $43 |
2014: 23 services
| Nuclear medicine study from skull base to mid-thigh with ct scan | 350 | $454,616 | $1,203 |
| Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 390 | $82,124 | $196 |
| Nuclear medicine study whole body with ct scan | 29 | $36,174 | $1,206 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 56 | $22,579 | $396 |
| Nuclear medicine study of brain with metabolic evaluation | 14 | $16,425 | $1,173 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 60 | $14,257 | $127 |
| Injection, regadenoson, 0.1 mg | 54 | $9,007 | None |
| Nuclear medicine study of bone and/or joint whole body | 29 | $6,078 | $210 |
| Nuclear medicine study of bone taken at different times | 20 | $5,876 | $294 |
| Nuclear medicine study of liver and bile duct system | 16 | $4,569 | $286 |
| Nuclear medicine study of parathyroid with spect and ct scan | 11 | $3,501 | $318 |
| Dxa bone density measurement of hip, pelvis, spine | 54 | $2,796 | $52 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 39 | $2,519 | $65 |
| Nuclear medicine study of heart pumping function by labeling red blood cells with measurement of internal blood volume ejected with every beat over multiple cycles | 12 | $2,362 | $197 |
| Technetium tc-99m labeled red blood cells, diagnostic, per study dose, up to 30 millicuries | 16 | $1,419 | $83 |
| Iodine i-123 sodium iodide, diagnostic, per 100 microcuries, up to 999 microcuries | 17 | $1,203 | $39 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) | 46 | $1,182 | $25 |
| Technetium tc-99m mebrofenin, diagnostic, per study dose, up to 15 millicuries | 18 | $730 | $41 |
| Nuclear medicine study of lung ventilation and circulation | 16 | $687 | $43 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 12 | $664 | $55 |
| Technetium tc-99m medronate, diagnostic, per study dose, up to 30 millicuries | 53 | $580 | $11 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 35 | $415 | $12 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 33 | $391 | $12 |
2013: 26 services
| Nuclear medicine study from skull base to mid-thigh with ct scan | 311 | $350,828 | $997 |
| Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 337 | $73,429 | $193 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 119 | $49,725 | $418 |
| Nuclear medicine study of bone and/or joint whole body | 138 | $29,154 | $210 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 129 | $28,263 | $114 |
| Nuclear medicine study whole body with ct scan | 26 | $27,723 | $990 |
| Injection, regadenoson, 0.1 mg | 109 | $18,377 | None |
| Indium in-111 labeled autologous white blood cells, diagnostic, per study dose | 13 | $11,251 | $865 |
| Nuclear medicine study of heart pumping function by labeling red blood cells with measurement of internal blood volume ejected with every beat over multiple cycles | 33 | $7,362 | $189 |
| Nuclear medicine study of bone taken at different times | 26 | $6,704 | $258 |
| Nuclear medicine study of liver and bile duct system with use of drugs | 20 | $5,762 | $288 |
| Nuclear medicine study of stomach to assess emptying | 18 | $4,495 | $250 |
| Iodine i-123 sodium iodide, diagnostic, per 100 microcuries, up to 999 microcuries | 23 | $4,158 | $90 |
| Nuclear medicine study of bone and/or joint multiple areas | 20 | $3,784 | $189 |
| Nuclear medicine study of thyroid and thyroid function | 19 | $3,780 | $199 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) | 116 | $3,274 | $28 |
| Technetium tc-99m labeled red blood cells, diagnostic, per study dose, up to 30 millicuries | 33 | $3,195 | $82 |
| Technetium tc-99m medronate, diagnostic, per study dose, up to 30 millicuries | 191 | $2,670 | $14 |
| Nuclear medicine study of kidney, blood, flow, and function with drug administration | 17 | $2,533 | $141 |
| Nuclear medicine study of radioactive material distribution at site of inflammation | 11 | $1,631 | $148 |
| Injection, sincalide, 5 micrograms | 20 | $1,134 | None |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 93 | $1,076 | $12 |
| Technetium tc-99m sulfur colloid, diagnostic, per study dose, up to 20 millicuries | 22 | $1,051 | $48 |
| Technetium tc-99m mebrofenin, diagnostic, per study dose, up to 15 millicuries | 24 | $979 | $41 |
| Technetium tc-99m pentetate, diagnostic, per study dose, up to 25 millicuries | 23 | $418 | $18 |
| Injection, furosemide, up to 20 mg | 14 | $29 | None |
Medicaid work
$27,582 in 2024
Medicaid paid $27,582 for 172 billed services this clinician did in 2024, up to 19 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Positron emission tomography (PET) with concurrently acquired computed tomography (CT) for attenuation correction and anatomical localization imaging; skull base to mid-thigh | 89 | $19,662 |
| Positron emission tomography (PET) with concurrently acquired computed tomography (CT) for attenuation correction and anatomical localization imaging; whole body | 16 | $7,301 |
| DXA BONE DENSITY STUDY 1/> SITES AXIAL SKEL | 67 | $618 |
| 2024 | 172 | 3 | 19 | $27,582 |
| 2023 | 285 | 3 | 30 | $45,582 |
| 2022 | 105 | 2 | 21 | $11,743 |
| 2021 | 96 | 2 | 22 | $9,303 |
| 2020 | 84 | 2 | 16 | $7,413 |
| 2019 | 110 | 2 | 31 | $15,495 |
| 2018 | 14 | 1 | 14 | $2,208 |
See the largest Medicaid services in earlier years
2023
| Positron emission tomography (PET) with concurrently acquired computed tomography (CT) for attenuation correction and anatomical localization imaging; skull base to mid-thigh | 198 | $41,574 |
| Positron emission tomography (PET) with concurrently acquired computed tomography (CT) for attenuation correction and anatomical localization imaging; whole body | 26 | $3,759 |
| DXA BONE DENSITY STUDY 1/> SITES AXIAL SKEL | 61 | $249 |
2022
| Positron emission tomography (PET) with concurrently acquired computed tomography (CT) for attenuation correction and anatomical localization imaging; skull base to mid-thigh | 69 | $11,531 |
| DXA BONE DENSITY STUDY 1/> SITES AXIAL SKEL | 36 | $213 |
2021
| Positron emission tomography (PET) with concurrently acquired computed tomography (CT) for attenuation correction and anatomical localization imaging; skull base to mid-thigh | 69 | $9,188 |
| DXA BONE DENSITY STUDY 1/> SITES AXIAL SKEL | 27 | $115 |
2020
| Positron emission tomography (PET) with concurrently acquired computed tomography (CT) for attenuation correction and anatomical localization imaging; skull base to mid-thigh | 43 | $7,230 |
| DXA BONE DENSITY STUDY 1/> SITES AXIAL SKEL | 41 | $183 |
2019
| Positron emission tomography (PET) with concurrently acquired computed tomography (CT) for attenuation correction and anatomical localization imaging; skull base to mid-thigh | 94 | $15,435 |
| DXA BONE DENSITY STUDY 1/> SITES AXIAL SKEL | 16 | $59 |
2018
| Positron emission tomography (PET) with concurrently acquired computed tomography (CT) for attenuation correction and anatomical localization imaging; skull base to mid-thigh | 14 | $2,208 |
Money from drug and device companies
$107 in 2025
| 2025 | 1 | 1 | None | $107 |
| 2024 | 1 | 1 | None | $144 |
| 2023 | 1 | 6 | None | $7,325 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Ge Healthcare | None | $107 | 1 payment
|
See the published payment
| Ge Healthcare | Meals · 2025-12-04 | None | $107 |
See earlier years (2024, 2023)
2024: $144
| Ge Healthcare | None | $144 | 1 payment
|
2023: $7,325
| GE HealthCare | None | $7,325 | 6 payments
|
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 76.5 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1194779561
- Licence
- CA A75921California A75921: Current · expires 2028-12-31
- Trained
- University of Southern California Keck School of Medicine, 2000
- Group
- Stanford Health Care
- Gender
- Male
More record details
- Sole proprietor
- No
- Medicaid ID
- CA 00A759210
- Taxonomy
- Federal specialty code 2085N0904X (2085N0904X); Federal specialty code 207U00000X (207U00000X)
- Mailing address
- 300 Pasteur Dr, Stanford, CA, 94305
- NPI first listed
- 2006-05-20
- NPI last updated
- 2024-04-09
- NPI record certified
- 2024-04-09
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 2801 K St, Sacramento, CA, 95816